Our Publications

  • Translation and Initial Psychometric Evaluation of Spanish Versions of Three Psychedelic Acute Effects Measures: Mystical, Challenging, and Insight Experiences

    Alan K. Davis, Christopher Timmermann, Ana Maria Ortiz Bernal, Rafaelle Lancelotta, Sandeep Nayak, Nathan D. Sepeda, Aki Nikolaidis & Roland R. Griffiths

    07/14/2023

  • Psychedelic literary studies and the poetics of disruption

    Neşe Devenot & George Erving

    06/09/2023

  • The evolution and ecology of psilocybin in nature

    Matthew Meyer & Jason Slot

    05/24/2023

  • Psychedelic Identity Shift: A Critical Approach to Set And Setting

    Neşe Devenot, Aidan Seale-Feldman, Elyse Smith, Tehseen Noorani, Albert Garcia-Romeu, Matthew W. Johnson

    02/07/2023

  • Inconsistencies between national drug policy and professional beliefs about psychoactive drugs among psychiatrists in the United States

    Adam Levin, Paul Nagib, Selina Deiparine, Thomas Gao, Justin Mitchell, Alan K. Davis

    08/11/2022

  • Applying Lessons From Cannabis to the Psychedelic Highway Buckle Up and Build Infrastructure

    Kevin F. Boehnke, Alan K. Davis & Jenna McAfee

    06/17/2022

  • Diversity, biology, and history of psilocybin-containing fungi: Suggestions for research and technological development

    R.C. Van Court, M.S. Wiseman, K.W. Meyer, D.J. Ballhorn, K.R. Amses, J.C. Slot, B.T.M. Dentinger, R. Garibay-Orijel, J.K. Uehling

    03/18/2022

  • A Precautionary Approach to Touch in Psychedelic-Assisted Therapy

    Neşe Devenot, Emma Tumilty, Meaghan Buisson, Sarah McNamee, David Nickles, and Lily Kay Ross

    03/09/2022

  • The acceptability of non-abstinent treatment goals among clinical social workers in the United States

    Yitong Xin, Megan España & Alan K. Davis

    03/01/2022

  • The clinical pharmacology and potential therapeutic applications of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT)

    Johannes T. Reckweg, Malin V. Uthaug, Attila Szabo, Alan K. Davis, Rafael Lancelotta, Natasha L. Mason, Johannes G. Ramaekers

    2/11/2022

  • Effects of Psychedelic Use on Racial Trauma Symptoms and Ethnic Identity among Asians in North America

    Terence H. W. Ching, Alan K. Davis, Yitong Xin & Monnica T. Williams

    01/11/2022

  • Knowledge, Perceptions, and Use of Psychedelics among Individuals with Fibromyalgia

    Nicolas G. Glynos, Jennifer Pierce, Alan K. Davis, Jenna McAfee & Kevin F. Boehnke

    01/10/2022

  • Right-Wing Psychedelia: Case Studies in Cultural Plasticity and Political Pluripotency

    Brian A. Pace & Neşe Devenot

    12/10/2021

  • Psychedelic treatment for co-occurring alcohol misuse and post-traumatic stress symptoms among United States Special Operations Forces Veterans

    Pratheek Mangini, Lynnette A. Averill, and Alan K. Davis

    11/15/2021

  • Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder

    Manoj K. Doss, Michal Považan, Monica D. Rosenberg, Nathan D. Sepeda, Alan K. Davis, Patrick H. Finan, Gwenn S. Smith, James J. Pekar, Peter B. Barker, Roland R. Griffiths & Frederick S. Barrett

    11/08/2021

  • Psychedelic medicalization, public discourse, and the morality of ego dissolution

    Alex K Gearin & Neşe Devenot

    06/09/2021

  • Medical Ecstasies: Chemical Synthesis and Self-Experimentation in Romantic Science and Poetry

    Neşe Devenot

    03/20/2019

  • Iterative l-Tryptophan Methylation in Psilocybe Evolved by Subdomain Duplication

    Felix Blei, Janis Fricke, Jonas Wick, Prof. Jason C. Slot, Prof. Dr. Dirk Hoffmeister

    08/11/2018

  • Horizontal gene cluster transfer increased hallucinogenic mushroom diversity

    Hannah T. Reynolds, Vinod Vijayakumar, Emile Gluck-Thaler, Hailee Brynn Korotkin, Patrick Brandon Matheny, Jason C. Slot

    02/27/2018

 Partner with us to help change the world.